No paywall

HOUSTON–(BUSINESS WIRE)–Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, today announced publication of the results of a study designed to evaluate the effects of COYA 303 (LD IL-2 and GLP-1RA), Coya’s investigational biologic combination to suppress pro-inflammatory myeloid cells, enhance … Read more

The study of consciousness is a field crowded with scientists, philosophers, and gurus. But neuroscientist Daniel Toker is focused on its shadow twin: unconsciousness. His path to this research began with a tragedy — one he witnessed firsthand. While at a music festival, a young concertgoer near Toker dove headfirst into a shallow lake. He … Read more

Related Stocks: COYA,

It’s not just talk. Americans’ spending on GLP-1 drugs including Ozempic and Wegovy has skyrocketed in the last five years. Spending hit $71.7 billion in 2023 for a 500% increase from $13.7 billion in 2018, according to a research letter published this month in JAMA Network Open , described…

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and accessibility. What’s keeping the pills from taking off?

2025-04-21T10:00:00.000Z Save this storySave this story Save this storySave this story In the past seventy-five years in America, the nutritional bar has gone from niche to mainstream. In the fifties, Bob Hoffman, of York, Pennsylvania, known as “the father of weightlifting,” and an early manufacturer of barbells, hawked a product called Hi-Proteen Honey Fudge. Made … Read more

The healthcare investor conference MedCity INVEST, scheduled for May 20-21 at the Willis Tower in Chicago, will spotlight a wide range of topics from GLP-1 drug coverage to investment trends and more. Register today! The post What Are Health Systems’ Strategic Priorities in 2025? appeared first on MedCity News.

My guest is Ryan Soave, LMHC, a leading expert in addiction recovery with extensive experience helping people heal from all types of substance and behavioral dependencies. We discuss actionable tools for breaking out of the addictive cycle and staying free of obsessions and compulsions. We also examine the relationship between trauma and addiction. We explore … Read more

Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world lose weight. The molecule is semaglutide, and it’s sold under the name Ozempic for type 2 diabetes and Wegovy for weight loss — but doctors have prescribed either for weight management. And this … Read more

Forget injections. A new drug promises to be just as effective as Ozempic  — but is taken as a daily pill. Called orforglipron, the results of a new clinical trial announced Thursday by manufacturer Eli Lilly suggest that the pill could be a breakthrough in a class of drugs called GLP-1 agonists, which have become … Read more